JPMorgan analyst Vivek Juneja upgraded BNY Mellon to Overweight citing the benefit from rate increases through higher net interest margin and recovery of money market fee waivers. The analyst keeps a $45 price target for the shares.

Argus analyst Stephen Biggar keeps a Buy rating and $67 price target on BNY Mellon after its Q1 earnings beat but raises its FY24 EPS view to $5.49 from $5.16 and its FY25 forecast to $5.97 from $5.69. Fee revenue growth for the company has resumed in 2024, supported by a healthy pipeline of mandates, even though its net interest income is expected to turn down about 10% on continued deposit pricing pressures, the analyst tells investors in a research note. An improving pre-tax margin and ROTCE should also aid the price-earnings multiple for BNY Mellon shares, Argus added.